Investment firm Biotech Growth Trust appoints Newgate

The Biotech Growth Trust, recently named the UK's best performing investment trust, has handed a retained brief to Newgate Communications.

'Maturing': Biotech sector
'Maturing': Biotech sector

The trust, managed by healthcare fund manager OrbiMed Capital, was launched in 2003. It has seen the best investment trust returns over the past five years (according to FE Trust Net) and a 50 per cent increase in its share price over the past 12 months.

It primarily invests in the worldwide biotechnology industry, principally in emerging biotech companies.

Newgate will handle the firm's financial and corporate comms and the win marks the first since Newgate owner Porta bought financial services specialist consultancy Cauldron in early March.

The agency is charged with helping to raise the profile of the trust among retail and institutional investors.

Anne McMeehan, director of Newgate Communications, said: 'The global biotech sector has matured over the past ten years and over this period the firm has been at the forefront of identifying and investing in emerging biotech firms.

'We believe there will be a continued resurgence in investment trusts and that with the pressures posed by an aging population, coupled with an increasing focus on new healthcare products, the trust is well placed to maximise returns.'

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus

Latest Articles

Max Clifford trial jury to reconvene tomorrow after majority verdicts direction

Max Clifford trial jury to reconvene tomorrow after majority verdicts direction

The jury in the trial of celebrity publicist Max Clifford on 11 charges of indecent assault has been sent home for the day after being told by the judge earlier this afternoon that he will now accept majority verdicts.

Labour "fooling themselves" over plans to combat attacks on Miliband

Labour "fooling themselves" over plans to combat attacks on Miliband

Conservative-leaning public affairs experts have questioned the value of Labour's adoption of US-style campaigning tactics in the wake of the opposition hiring election strategist David Axelrod.

PLMR appoints Professor Tim Morris as non-executive director

The vet who helped establish the British Horseracing Authority's anti-doping and animal welfare programme has joined PLMR as a non-executive director.